Literature DB >> 27889115

New psychoactive substances: Are there any good options for regulating new psychoactive substances?

Peter Reuter1, Bryce Pardo2.   

Abstract

Advances in chemistry, technology, and globalization have contributed to the rapid development and diffusion of NPS (new psychoactive substances), creating perhaps the most serious challenge to the century-old international drug control system and to national systems. Very little is known about the effects of these substances which fall outside of national and international controls. The predominant response to the flood of NPS has been the development of more expeditious methods of prohibiting a new chemical entity. This article explores alternative mechanisms that have been considered: foodstuffs, alcohol and tobacco and medicines. None seems promising in terms of avoiding the problems of prohibition without permitting unsafe substances on the market. The article then considers whether there is a bias in the existing system toward excessive prohibition. In public discussion, no attention is given to the pleasures that users obtain from any NPS, to the possibility of substitution for a more dangerous legal or illegal drug or to the consequences of illegal markets for prohibited NPS. On the other hand, it may well be impossible to obtain meaningful assessments on any of these matters at the time when decisions are made. These complexities have led a number of countries, most recently Australia and the UK, to impose total bans, the effects of which are impossible to predict.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Legal highs; New psychoactive substances; Prohibition; Regulation

Mesh:

Substances:

Year:  2016        PMID: 27889115     DOI: 10.1016/j.drugpo.2016.10.020

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  5 in total

1.  Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Authors:  Francois R Lamy; Raminta Daniulaityte; Ramzi W Nahhas; Monica J Barratt; Alan G Smith; Amit Sheth; Silvia S Martins; Edward W Boyer; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2017-06-01

2.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

3.  Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones.

Authors:  Morgan Philp; Ronald Shimmon; Mark Tahtouh; Shanlin Fu
Journal:  J Vis Exp       Date:  2018-02-05       Impact factor: 1.355

4.  New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.

Authors:  Eliza Kurcevič; Rick Lines
Journal:  Harm Reduct J       Date:  2020-11-30

5.  The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.

Authors:  Yuko Tanibuchi; Toshihiko Matsumoto; Daisuke Funada; Takuya Shimane
Journal:  Neuropsychopharmacol Rep       Date:  2018-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.